William Blair Initiates Coverage On Palvella Therapeutics with Outperform Rating
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsInitiation
William Blair analyst Alethia Young initiates coverage on Palvella Therapeutics (NASDAQ:PVLA) with a Outperform rating.
William Blair analyst Alethia Young initiates coverage on Palvella Therapeutics (NASDAQ:PVLA) with a Outperform rating.